US National Children's Hospital
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
Heidelberg University Hospital
Genetic Modification Of Immune Cells To Make Them Tireless, Cold-Blooded "Cancer Cell Killers"!
Cabozantinib In Combination With Atelizumab Works Well For Advanced Head And Neck Cancer
Living cell anti-aging therapy is quietly emerging